Table 1.

Baseline characteristics of women in cohort data.

	Entire cohort	PCOS	non PCOS	P value
Total no	558,302	2039	556,263	< .001
Non-infectious uveitis incidence per 10,000 person-years	16.6	35.1	16.6
Age, mean (SD)	39.3 (22.7)	28.6 (7.0)	39.3 (22.7)	< .001
Region of residence
Rural	261,709 (46.9)	1,044 (51.2)	260,665 (46.9)	.73
Urban	235,034 (42.1)	923 (45.3)	234,111 (42.1)
Missing	61,559 (11.0)	72 (3.5)	61,487 (11.0)
Household income
0–30%	90,082 (16.1)	292 (14.3)	89,790 (16.1)	< .001
30–70%	163,619 (29.3)	745 (36.5)	162,874 (29.3)
70–100%	243,042 (43.5)	930 (45.6)	242,112 (43.5)
Missing	61,559 (11.0)	72 (3.5)	61,487 (11.1)
Diabetes	61,861 (11.1)	158 (7.7)	61,703 (11.1)	< .001
Hypertension	117,953 (21.1)	96 (4.7)	117,857 (21.2)	< .001
Cardiovascular disease	58,471 (10.5)	53 (2.6)	58,418 (10.5)	< .001
Chronic kidney disease	29,023 (5.2)	79 (3.9)	28,944 (5.2)	.007
Charlson Comorbidity index
0	102,915 (18.4)	302 (14.8)	102,613 (18.4)	< .001
1	158,563 (28.4)	553 (27.1)	158,010 (28.4)
2 and more	296,824 (53.2)	1,184 (58.1)	295,640 (53.1)
Comorbidity
Behcet’s disease	860 (0.15)	7 (0.34)	853 (0.15)	.03
Juvenile idiopathic arthritis	217 (0.04)	5 (0.25)	212 (0.04)	< .001
Ankylosing spondylitis	3342 (0.60)	3 (0.15)	3339 (0.60)	.008
Systemic lupus erythematosus	1241 (0.22)	7 (0.34)	1234 (0.22)	.25
Ulcerative colitis	1691 (0.30)	7 (0.34)	1684 (0.30)	.74
Tuberculosis	8814 (1.58)	30 (1.47)	8784 (1.58)	.70
Sarcoidosis	75 (0.01)	0 (0)	75 (0.01)	.60
Crohn’s disease	1009 (0.18)	2 (0.10)	1,007 (0.18)	.38
Multiple sclerosis	178 (0.03)	2 (0.10)	176 (0.03)	.09
Reactive arthritis	1306 (0.23)	4 (0.20)	1302 (0.23)	.72

PCOS Polycystic ovary syndrome.

Data are presented as No. (%).